Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events-Reference-Cited by-同舟云学术

Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events

Published:2020-03 Issue: Volume:128 Page:17-26
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Cortellini Alessio,Bersanelli Melissa,Santini Daniele,Buti Sebastiano,Tiseo Marcello,Cannita Katia,Perrone Fabiana,Giusti Raffaele,De Tursi Michele,Zoratto Federica,Marconcini Riccardo,Russano Marco,Zeppola Tea,Anesi Cecilia,Filetti Marco,Marchetti Paolo,Botticelli Andrea,Gelibter Alain,De Galitiis Federica,Vitale Maria Giuseppa,Rastelli Francesca,Tudini Marianna,Silva Rosa Rita,Atzori Francesco,Chiari Rita,Ricciuti Biagio,De Giglio Andrea^ORCID,Migliorino Maria Rita,Mallardo Domenico^ORCID,Vanella Vito,Mosillo Claudia,Bracarda Sergio,Rinaldi Silvia,Berardi Rossana,Natoli Clara,Ficorella Corrado,Porzio Giampiero,Ascierto Paolo A.

Funder

Consorzio Interuniversitario Nazionale per la Bio-Oncologia

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference43 articles.

1. Modifiable host factors in melanoma: emerging evidence for obesity, diet, exercise, and the microbiome;Warner;Curr Oncol Rep,2019

2. Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non-small cell lung cancer patients: a "hypothesis-generator" preliminary report;Cortellini;Thorac Cancer,2019

3. Complex inter-relationship of body mass index, gender and serum creatinine on survival: exploring the obesity paradox in melanoma patients treated with checkpoint inhibition;Naik;J Immunother Cancer,2019

4. Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis;McQuade;Lancet Oncol,2018

5. Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade;Wang;Nat Med,2018

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Relationship between Proinflammatory Molecules and PD-L1 in Patients with Obesity Who Underwent Gastric Sleeve Surgery—A Pilot Study;Reports;2024-09-03

2. The Effect of Body Mass Index on Melanoma Biology, Immunotherapy Efficacy, and Clinical Outcomes: A Narrative Review;International Journal of Molecular Sciences;2024-06-11

3. Body Composition in Advanced Non-Small Cell Lung Cancer Treated With Immunotherapy;JAMA Oncology;2024-06-01

4. Effect of body mass index and cholesterol‐rich apolipoprotein‐B‐containing lipoproteins on clinical outcome in NSCLC patients treated with immune checkpoint inhibitors‐based therapy: A retrospective analysis;Cancer Medicine;2024-05-31

5. Impact of body mass index on the prognosis of unresectable HCC patients receiving first‐line Lenvatinib or atezolizumab plus bevacizumab;Liver International;2024-03-22